NDC 44911-0652
Influenzinum 200C
Influenzinum (2021-2022)
Influenzinum 200C is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Energique, Inc.. The primary component is Influenza A Virus A/tasmania/503/2020 Ivr-221 (h3n2) Antigen (formaldehyde Inactivated); Influenza A Virus A/victoria/2570/2019 Ivr-215 (h1n1) Antigen (formaldehyde Inactivated); Influenza B Virus B/phuket/3073/2013 Antigen (formaldehyde Inactivated); Influenza B Virus B/washington/02/2019 Antigen (formaldehyde Inactivated).
| Product ID | 44911-0652_9577b1f9-bb12-4371-b692-759612382fbf |
| NDC | 44911-0652 |
| Product Type | Human Otc Drug |
| Proprietary Name | Influenzinum 200C |
| Generic Name | Influenzinum (2021-2022) |
| Dosage Form | Liquid |
| Route of Administration | ORAL |
| Marketing Start Date | 2022-02-15 |
| Marketing End Date | 2027-03-30 |
| Marketing Category | UNAPPROVED HOMEOPATHIC / |
| Labeler Name | Energique, Inc. |
| Substance Name | INFLUENZA A VIRUS A/TASMANIA/503/2020 IVR-221 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED) |
| Active Ingredient Strength | 200 [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL |
| NDC Exclude Flag | N |